Literature DB >> 10884238

Bupropion: a new treatment for smokers. Nicotine replacement treatment should also be available on the NHS.

J Britton, M J Jarvis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10884238      PMCID： PMC1127748          DOI： 10.1136/bmj.321.7253.65

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

1.  Prescription of transdermal nicotine patches for smoking cessation in general practice: evaluation of cost-effectiveness.

Authors:  J A Stapleton; A Lowin; M A Russell
Journal:  Lancet       Date:  1999-07-17       Impact factor: 79.321

2.  Guidance for commissioners on the cost effectiveness of smoking cessation interventions. Health Educational Authority.

Authors:  S Parrott; C Godfrey; M Raw; R West; A McNeill
Journal:  Thorax       Date:  1998-12       Impact factor: 9.139

3.  A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

Authors:  D E Jorenby; S J Leischow; M A Nides; S I Rennard; J A Johnston; A R Hughes; S S Smith; M L Muramoto; D M Daughton; K Doan; M C Fiore; T B Baker
Journal:  N Engl J Med       Date:  1999-03-04       Impact factor: 91.245

4.  Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism.

Authors:  K E Hayford; C A Patten; T A Rummans; D R Schroeder; K P Offord; I T Croghan; E D Glover; D P Sachs; R D Hurt
Journal:  Br J Psychiatry       Date:  1999-02       Impact factor: 9.319

5.  A comparison of sustained-release bupropion and placebo for smoking cessation.

Authors:  R D Hurt; D P Sachs; E D Glover; K P Offord; J A Johnston; L C Dale; M A Khayrallah; D R Schroeder; P N Glover; C R Sullivan; I T Croghan; P M Sullivan
Journal:  N Engl J Med       Date:  1997-10-23       Impact factor: 91.245

Review 6.  Bupropion: a review of its mechanism of antidepressant activity.

Authors:  J A Ascher; J O Cole; J N Colin; J P Feighner; R M Ferris; H C Fibiger; R N Golden; P Martin; W Z Potter; E Richelson
Journal:  J Clin Psychiatry       Date:  1995-09       Impact factor: 4.384
  6 in total
  10 in total

1.  Bupropion for smokers. Bupropion may not be as good as editorial implies.

Authors:  C Harrison
Journal:  BMJ       Date:  2001-02-17

2.  Moving tobacco control beyond "the tipping point".

Authors:  R M Davis
Journal:  BMJ       Date:  2000-08-05

Review 3.  Smoking cessation: integrating recent advances into clinical practice.

Authors:  T Coleman
Journal:  Thorax       Date:  2001-07       Impact factor: 9.139

4.  Newly available treatments for nicotine addiction. Smokers wanting help with stopping now have effective treatment options.

Authors:  T Coleman; R West
Journal:  BMJ       Date:  2001-05-05

Review 5.  Current approaches to the management of smoking cessation.

Authors:  Gay Sutherland
Journal:  Drugs       Date:  2002       Impact factor: 9.546

6.  Nicotine replacement therapy in pregnancy.

Authors:  Tim Coleman; John Britton; Jim Thornton
Journal:  BMJ       Date:  2004-04-24

7.  Smoking cessation treatment in primary care: prospective cohort study.

Authors:  A Wilson; J Hippisley-Cox; C Coupland; T Coleman; J Britton; S Barrett
Journal:  Tob Control       Date:  2005-08       Impact factor: 7.552

Review 8.  The role of pharmacotherapy in assisting smoking cessation.

Authors:  W Stephen Waring
Journal:  Eur J Clin Pharmacol       Date:  2003-07-25       Impact factor: 2.953

9.  Seizures after overdoses of bupropion intake.

Authors:  Hasan Kara; Ahmet Ak; Ayşegül Bayır; Demet Acar; Rabia Istanbulluoğlu; Selim Değirmenci
Journal:  Balkan Med J       Date:  2013-06-01       Impact factor: 2.021

10.  Protocol for the smoking, nicotine and pregnancy (SNAP) trial: double-blind, placebo-randomised, controlled trial of nicotine replacement therapy in pregnancy.

Authors:  Tim Coleman; Jim Thornton; John Britton; Sarah Lewis; Kim Watts; Michael W H Coughtrie; Clare Mannion; Neil Marlow; Christine Godfrey
Journal:  BMC Health Serv Res       Date:  2007-01-03       Impact factor: 2.655
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.